V. Sundaresan

Takeda (United States) — United States

Medicine · Health Sciences

11h-index745citations25works0.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(5), RNA modifications and cancer(5), Cancer Genomics and Diagnostics(3), Lung Cancer Research Studies(3), Cancer Immunotherapy and Biomarkers(2)

Publications25 total

Nutritional modification in prostate cancer: A narrative review of dietary factors in risk and progression
Clinical Nutrition ESPEN·2025
804P A novel artificial intelligence (AI) imaging biomarker of tumour vascularity and heterogeneity radiomics to predict survival benefit of fruquintinib vs placebo in metastatic colorectal cancer (mCRC)
Annals of Oncology·2025· 1 cited
32P A novel imaging biomarker, quantitative vessel tortuosity, captures the antiangiogenic effect of fruquintinib in metastatic colorectal cancer
Annals of Oncology·2025· 1 citedOpen Access
Pathologic gleason upgrading following high-resolution micro-ultrasound, conventional ultrasound and MRI fusion biopsy techniques: A comparative study
European Urology·2024· 1 cited
Effectiveness of 7.5 Percent Povidone Iodine in Comparison to 1 Percent Clotrimazole with Lignocaine in the Treatment of Otomycosis
ISRN Otolaryngology·2013· 29 citedOpen Access
A Reclusive Foreign Body in the Airway: A Case Report and a Literature Review
Case Reports in Otolaryngology·2013· 10 citedOpen Access
269 Ki67 in Breast Cancer Patients and Its Correlation with Clinico Pathological Factors
European Journal of Cancer·2012· 2 cited
Metasin – a rapid and robust PCR assay for intra-operative sentinel node diagnosis
European Journal of Surgical Oncology·2010· 1 cited
105PD SEQUENTIAL CHEMORADIATION AND RADIATION ALONE IN THE TREATMENT OF INOPERABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND CORRELATION OF TUMOUR ERCC1 WITH SURVIVAL
Lung Cancer·2009
Characterization of a Chromosomally Complex Lung Cancer Cell Line Using Multiwell Fluorescence In Situ Hybridization
Cancer Genetics and Cytogenetics·2000· 2 cited
Genome wide search for genetic damage in p53 transgenic mouse lung tumours reveals consistent loss of chromosome 4
European Journal of Cancer·1997· 4 cited
Clonal evolution of lung tumors
Lung Cancer·1996· 41 cited
Sequential molecular genetic changes in lung cancer development
Lung Cancer·1996· 96 cited
Somatic genetic changes in lung cancer and precancerous lesions
Annals of Oncology·1995· 29 citedOpen Access
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus
Lung Cancer·1993· 259 cited
Deletion mapping of chromosome 3 in lung tumours
Lung Cancer·1993
Paraffin wax‐embedded material as a source of DNA for the detection of somatic genetic changes
The Journal of Pathology·1993· 9 cited
Primitive neuroectodermal tumour of the uterus
Histopathology·1992· 27 cited
Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.
PubMed·1992· 11 cited
Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours
British Journal of Cancer·1991· 86 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Pamela Rabbitts(7), P S Hasleton(5), Peter Ganly(3), R.M. Rudd(3), N. M. Bleehen(2), Grace Chung(2), J G Reeve(2), D. G. D. Wight(2), Maria C. Daly(2), Jenny Douglas(2), N M Bleehen(2), Ajay Philip(2), Regi Thomas(2), Anand Job(2), Amanda Heppell-Parton(2), J. Watson(2), S. Jader(2), S. Lonardi(2), Ozlem Yardibi(2), Nagasen Dasari(2)